Angeles Wealth Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,237
Closed -$441K – 654
2026
Q2
$441K Sell
6,237
-843
-12% -$45.5K 0.02% 302
2026
Q1
$370K Buy
7,080
+550
+8% +$33K 0.02% 283
2025
Q4
$384K Buy
6,530
+827
+15% +$50.2K 0.02% 251
2025
Q3
$317K Buy
5,703
+189
+3% +$10.1K 0.02% 248
2025
Q2
$284K Buy
5,514
+1,464
+36% +$73.6K 0.02% 272
2025
Q1
$237K Buy
4,050
+13
+0.3% +$881 0.02% 258
2024
Q4
$291K Buy
4,037
+85
+2% +$6.24K 0.02% 219
2024
Q3
$316K Buy
+3,952
New +$297K 0.03% 192

Other funds holding TECH

Angeles Wealth Management's TECH Position: Q3 2026 in Review

Angeles Wealth Management sold out of Bio-Techne (TECH) in Q3 2026, closing a stake of 6,237 shares — an estimated $441K sold.

Angeles Wealth Management first reported a position in TECH in Q3 2024 and held it in 8 quarters. The position peaked at $441K in Q2 2026. 586 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Angeles Wealth Management reported no remaining Bio-Techne position as of Q3 2026 after selling out during the quarter.
  • Angeles Wealth Management sold 6,237 Bio-Techne shares in Q3 2026, an estimated $441K.
  • Angeles Wealth Management first reported a position in Bio-Techne in Q3 2024 and held it in 8 quarters.
  • Angeles Wealth Management's Bio-Techne position peaked at $441K in Q2 2026.
  • 586 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Angeles Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.